These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 22055592

  • 1. Evaluation of serum LINE-1 hypomethylation as a prognostic marker for hepatocellular carcinoma.
    Ramzy II, Omran DA, Hamad O, Shaker O, Abboud A.
    Arab J Gastroenterol; 2011 Sep; 12(3):139-42. PubMed ID: 22055592
    [Abstract] [Full Text] [Related]

  • 2. Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma.
    Tangkijvanich P, Hourpai N, Rattanatanyong P, Wisedopas N, Mahachai V, Mutirangura A.
    Clin Chim Acta; 2007 Apr; 379(1-2):127-33. PubMed ID: 17303099
    [Abstract] [Full Text] [Related]

  • 3. Genome-wide hypomethylation in hepatocellular carcinogenesis.
    Lin CH, Hsieh SY, Sheen IS, Lee WC, Chen TC, Shyu WC, Liaw YF.
    Cancer Res; 2001 May 15; 61(10):4238-43. PubMed ID: 11358850
    [Abstract] [Full Text] [Related]

  • 4. LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas.
    Harada K, Baba Y, Ishimoto T, Chikamoto A, Kosumi K, Hayashi H, Nitta H, Hashimoto D, Beppu T, Baba H.
    Ann Surg Oncol; 2015 Apr 15; 22(4):1280-7. PubMed ID: 25319577
    [Abstract] [Full Text] [Related]

  • 5. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma.
    Lee HS, Kim BH, Cho NY, Yoo EJ, Choi M, Shin SH, Jang JJ, Suh KS, Kim YS, Kang GH.
    Clin Cancer Res; 2009 Feb 01; 15(3):812-20. PubMed ID: 19188151
    [Abstract] [Full Text] [Related]

  • 6. Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer.
    Saito K, Kawakami K, Matsumoto I, Oda M, Watanabe G, Minamoto T.
    Clin Cancer Res; 2010 Apr 15; 16(8):2418-26. PubMed ID: 20371677
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL, Du Z.
    Zhonghua Zhong Liu Za Zhi; 2008 Nov 15; 30(11):831-6. PubMed ID: 19173828
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma.
    Ng KT, Qi X, Kong KL, Cheung BY, Lo CM, Poon RT, Fan ST, Man K.
    Eur J Cancer; 2011 Oct 15; 47(15):2299-305. PubMed ID: 21683576
    [Abstract] [Full Text] [Related]

  • 10. Serum C-reactive protein levels predict survival in hepatocellular carcinoma.
    Nagaoka S, Yoshida T, Akiyoshi J, Akiba J, Torimura T, Adachi H, Kurogi J, Tajiri N, Inoue K, Niizeki T, Koga H, Imaizumi T, Kojiro M, Sata M.
    Liver Int; 2007 Oct 15; 27(8):1091-7. PubMed ID: 17845537
    [Abstract] [Full Text] [Related]

  • 11. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
    Lee MJ, Yu GR, Park SH, Cho BH, Ahn JS, Park HJ, Song EY, Kim DG.
    Clin Cancer Res; 2008 Feb 15; 14(4):1080-9. PubMed ID: 18281540
    [Abstract] [Full Text] [Related]

  • 12. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
    Wong IH, Lo YM, Zhang J, Liew CT, Ng MH, Wong N, Lai PB, Lau WY, Hjelm NM, Johnson PJ.
    Cancer Res; 1999 Jan 01; 59(1):71-3. PubMed ID: 9892188
    [Abstract] [Full Text] [Related]

  • 13. [Prevalence and prognostic value of serum anti-p53 antibodies in hepatocellular carcinoma. A study of 159 patients].
    Sitruk V, Vaysse J, Chevret S, Ganne-Carrie N, Christidis C, Trinchet J, Beaugrand M.
    Gastroenterol Clin Biol; 2000 Dec 01; 24(12):1159-63. PubMed ID: 11173728
    [Abstract] [Full Text] [Related]

  • 14. Hypomethylation of long interspersed nuclear element-1 promoter is associated with poor outcomes for curative resected hepatocellular carcinoma.
    Gao XD, Qu JH, Chang XJ, Lu YY, Bai WL, Wang H, Xu ZX, An LJ, Wang CP, Zeng Z, Yang YP.
    Liver Int; 2014 Jan 01; 34(1):136-46. PubMed ID: 23875825
    [Abstract] [Full Text] [Related]

  • 15. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein.
    Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, Surzycki SJ, Lee YI.
    Gastroenterology; 2007 Apr 01; 132(4):1476-94. PubMed ID: 17408664
    [Abstract] [Full Text] [Related]

  • 16. Increased Golgi protein 73 expression in hepatocellular carcinoma tissue correlates with tumor aggression but not survival.
    Sun Y, Yang H, Mao Y, Xu H, Zhang J, Li G, Lu X, Sang X, Zhao H, Zhong S, Huang J, Zhang H.
    J Gastroenterol Hepatol; 2011 Jul 01; 26(7):1207-12. PubMed ID: 21443671
    [Abstract] [Full Text] [Related]

  • 17. Elevated serum vitamin B(12) levels in association with tumor markers as the prognostic factors predictive for poor survival in patients with hepatocellular carcinoma.
    Lin CY, Kuo CS, Lu CL, Wu MY, Huang RF.
    Nutr Cancer; 2010 Jul 01; 62(2):190-7. PubMed ID: 20099193
    [Abstract] [Full Text] [Related]

  • 18. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
    Poon RT, Lau C, Pang R, Ng KK, Yuen J, Fan ST.
    Ann Surg Oncol; 2007 Jun 01; 14(6):1835-45. PubMed ID: 17406950
    [Abstract] [Full Text] [Related]

  • 19. Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection.
    Liu ZJ, Huang Y, Wei L, He JY, Liu QY, Yu XQ, Li ZL, Zhang J, Li B, Sun CJ, Liang WB, Sun AM, Qin Y.
    Neoplasma; 2017 Jun 01; 64(5):795-802. PubMed ID: 28592132
    [Abstract] [Full Text] [Related]

  • 20. Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.
    Huo TI, Huang YH, Lui WY, Wu JC, Lee PC, Chang FY, Lee SD.
    Oncol Rep; 2004 Feb 01; 11(2):543-50. PubMed ID: 14719097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.